<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:vaso="http://vasocorporation.com/20251231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vaso-20251231.xsd" xlink:type="simple"/>
    <context id="cref_1871211131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="cref_2118415476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vaso:Equity-BasedAwardsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="cref_1230425566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="cref_441293347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2028475254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1786281745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="cref_1591332837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="cref_992077632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_385880636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="cref_1813546179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000839087</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="uref_1871211131">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="cref_2028475254" id="fc_408965188">DEF 14A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="cref_2028475254" id="ixv-2351">0000839087</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_2028475254" id="ixv-2352">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="cref_2028475254" id="ixv-2438">VASO CORPORATION</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="cref_2028475254" id="ixv-2439">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="cref_2028475254" id="ixv-2440">Equity awards, including stock options, are not granted in anticipation of the release of material non-public information, and the release of material non-public information is not timed on the basis of option or other equity grant dates. The Company did not have any equity awards outstanding to its named executive officers at December 31, 2025.</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="cref_2028475254" id="ixv-2441">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="cref_2028475254" id="ixv-2442">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="cref_2028475254" id="ixv-1777">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in;"&gt;Pay versus Performance&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in;"&gt;In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the following disclosure regarding executive compensation for our principal executive officer (&#x201c;PEO&#x201d;) and non-PEO Named Executive Officers and Company performance for the years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.3pt; text-align: justify; text-indent: 0.4in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&lt;span style="font-weight: bold;"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Summary &lt;br/&gt; Compensation &lt;br/&gt; Table &lt;br/&gt; Total for PEO (1)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Compensation &lt;br/&gt; Actually Paid to &lt;br/&gt; PEO (1)(2)(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Average Summary &lt;br/&gt; Compensation Table&lt;br/&gt;  Total for Non-PEO     NEOs (1)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Average &lt;br/&gt; Compensation &lt;br/&gt; Actually Paid to Non-&lt;br/&gt; PEO NEOs     (1)(2)(4)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Value of Initial&lt;br/&gt;  Fixed $100&lt;br/&gt;  Investment&lt;br/&gt;  Based on TSR     &lt;br/&gt; (5)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;span style="font-weight: bold;"&gt;Net Income&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 28%; text-align: justify;"&gt;2025&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;807,485&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;807,485&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;563,581&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;563,581&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;100&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,569,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;2024&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;756,635&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;756,635&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;544,258&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;534,758&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;71&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;951,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;2023&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;921,610&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;971,610&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;549,109&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;584,109&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;182&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;4,805,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.5pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt;(1)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;The PEO for all years was Jun Ma. The non-PEO NEOs for all years were Jane Moen and Jonathan Newton.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(2)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company&#x2019;s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnotes 3 and 4 below. Equity values are calculated in accordance with FASB ASC Topic 718.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(3)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;To calculate the amounts of Compensation Actually Paid to the PEO in each of 2025, 2024 and 2023, the following adjustments were made to the PEO&#x2019;s Summary Compensation Table Total for each respective year:&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0;"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;a.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2025: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;b.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2024: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;c.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2023: We added $50,000, reflecting, as of the applicable vesting date, the change in the fair value during 2023 of equity-based awards granted to the PEO before 2023 that vested during 2023.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(4)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;To calculate the amounts of Compensation Actually Paid, on average, to our non-PEO NEOs in each of 2025, 2024 and 2023, the following adjustments were made to the Average Summary Compensation Table Total for Non-PEO NEOs for each respective year:&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;a.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2025: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;b.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2024: We deducted $9,500, reflecting, as of the applicable vesting date, the change in the fair value during 2024 of equity-based awards granted to the non-PEO NEOs before 2024 that vested during 2024.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;c.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2023: We (i) added $21,000, reflecting the change in the fair value during 2023 of equity-based awards granted to the non-PEO NEOs before 2023 that were outstanding and unvested as of the end of 2023; and (ii) added $14,000, reflecting, as of the applicable vesting date, the change in the fair value during 2023 of equity-based awards granted to the non-PEO NEOs before 2023 that vested during 2023.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(5)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;The values disclosed in this TSR column represent the measurement period value of an investment of $100 in our common stock as of December 31, 2022, and then valued again on each of December 31, 2023, December 31, 2024 and December 31, 2025. Historical stock performance is not necessarily indicative of future stock performance.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="cref_2028475254"
      decimals="0"
      id="fc_913332359"
      unitRef="uref_1871211131">807485</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="cref_2028475254"
      decimals="0"
      id="fc_1426426644"
      unitRef="uref_1871211131">807485</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="cref_2028475254"
      decimals="0"
      id="fc_510040926"
      unitRef="uref_1871211131">563581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="cref_2028475254"
      decimals="0"
      id="fc_839152154"
      unitRef="uref_1871211131">563581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="cref_2028475254"
      decimals="0"
      id="fc_1719243974"
      unitRef="uref_1871211131">100</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2028475254"
      decimals="0"
      id="ixv-2448"
      unitRef="uref_1871211131">1569000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="cref_1813546179"
      decimals="0"
      id="fc_1346628092"
      unitRef="uref_1871211131">756635</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="cref_1813546179"
      decimals="0"
      id="fc_82836388"
      unitRef="uref_1871211131">756635</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="cref_1813546179"
      decimals="0"
      id="fc_344497939"
      unitRef="uref_1871211131">544258</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="cref_1813546179"
      decimals="0"
      id="fc_1770273030"
      unitRef="uref_1871211131">534758</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="cref_1813546179"
      decimals="0"
      id="fc_1118739305"
      unitRef="uref_1871211131">71</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1813546179"
      decimals="0"
      id="ixv-2454"
      unitRef="uref_1871211131">951000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="cref_385880636"
      decimals="0"
      id="fc_1339200806"
      unitRef="uref_1871211131">921610</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="cref_385880636"
      decimals="0"
      id="fc_980923542"
      unitRef="uref_1871211131">971610</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="cref_385880636"
      decimals="0"
      id="fc_1180171186"
      unitRef="uref_1871211131">549109</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="cref_385880636"
      decimals="0"
      id="fc_289300448"
      unitRef="uref_1871211131">584109</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="cref_385880636"
      decimals="0"
      id="fc_745249098"
      unitRef="uref_1871211131">182</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="cref_385880636"
      decimals="0"
      id="ixv-2460"
      unitRef="uref_1871211131">4805000</us-gaap:NetIncomeLoss>
    <ecd:PeoName contextRef="cref_2028475254" id="ixv-2462">Jun Ma</ecd:PeoName>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="cref_2028475254" id="ixv-2463">Jane Moen and Jonathan Newton</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="cref_2028475254" id="ixv-1929">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(3)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;To calculate the amounts of Compensation Actually Paid to the PEO in each of 2025, 2024 and 2023, the following adjustments were made to the PEO&#x2019;s Summary Compensation Table Total for each respective year:&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0;"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;a.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2025: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;b.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2024: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;c.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2023: We added $50,000, reflecting, as of the applicable vesting date, the change in the fair value during 2023 of equity-based awards granted to the PEO before 2023 that vested during 2023.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToCompAmt
      contextRef="cref_992077632"
      decimals="0"
      id="ixv-2465"
      unitRef="uref_1871211131">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="cref_1591332837"
      decimals="0"
      id="ixv-2466"
      unitRef="uref_1871211131">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="cref_1786281745"
      decimals="0"
      id="ixv-2467"
      unitRef="uref_1871211131">50000</ecd:AdjToCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="cref_2028475254" id="ixv-1955">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;(4)&lt;/td&gt; &lt;td style="text-align: justify;"&gt;To calculate the amounts of Compensation Actually Paid, on average, to our non-PEO NEOs in each of 2025, 2024 and 2023, the following adjustments were made to the Average Summary Compensation Table Total for Non-PEO NEOs for each respective year:&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: justify;"&gt;a.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2025: None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;b.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2024: We deducted $9,500, reflecting, as of the applicable vesting date, the change in the fair value during 2024 of equity-based awards granted to the non-PEO NEOs before 2024 that vested during 2024.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="text-align: justify; width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="text-align: justify; width: 0.25in;"&gt;c.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;Year 2023: We (i) added $21,000, reflecting the change in the fair value during 2023 of equity-based awards granted to the non-PEO NEOs before 2023 that were outstanding and unvested as of the end of 2023; and (ii) added $14,000, reflecting, as of the applicable vesting date, the change in the fair value during 2023 of equity-based awards granted to the non-PEO NEOs before 2023 that vested during 2023.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToCompAmt
      contextRef="cref_441293347"
      decimals="0"
      id="ixv-2468"
      unitRef="uref_1871211131">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="cref_1230425566"
      decimals="0"
      id="ixv-2469"
      unitRef="uref_1871211131">9500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="cref_2118415476"
      decimals="0"
      id="ixv-2470"
      unitRef="uref_1871211131">21000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="cref_1871211131"
      decimals="0"
      id="ixv-2471"
      unitRef="uref_1871211131">14000</ecd:AdjToCompAmt>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1770273030"
          xlink:label="fc_1770273030"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_289300448"
          xlink:label="fc_289300448"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_839152154"
          xlink:label="fc_839152154"
          xlink:type="locator"/>
        <link:footnote id="fref_1509367160" xlink:label="fref_1509367160" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">To calculate the amounts of Compensation Actually Paid, on average, to our non-PEO NEOs in each of 2025,
2024 and 2023, the following adjustments were made to the Average Summary Compensation Table Total for Non-PEO NEOs for each respective
year:<xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top; text-align: justify;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="width: 0.25in; text-align: justify;">a.</xhtml:td><xhtml:td style="text-align: justify;">Year 2025: None</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="text-align: justify; width: 0.25in;">b.</xhtml:td><xhtml:td style="text-align: justify;">Year 2024: We deducted $9,500, reflecting, as of the applicable vesting date, the change in the fair value during 2024 of equity-based
awards granted to the non-PEO NEOs before 2024 that vested during 2024.</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="text-align: justify; width: 0.25in;">c.</xhtml:td><xhtml:td style="text-align: justify;">Year 2023: We (i) added $21,000, reflecting the change in the fair value during 2023 of equity-based awards granted to the non-PEO
NEOs before 2023 that were outstanding and unvested as of the end of 2023; and (ii) added $14,000, reflecting, as of the applicable vesting
date, the change in the fair value during 2023 of equity-based awards granted to the non-PEO NEOs before 2023 that vested during 2023.</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1770273030"
          xlink:to="fref_1509367160"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_289300448"
          xlink:to="fref_1509367160"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_839152154"
          xlink:to="fref_1509367160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_980923542"
          xlink:label="fc_980923542"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1426426644"
          xlink:label="fc_1426426644"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_82836388"
          xlink:label="fc_82836388"
          xlink:type="locator"/>
        <link:footnote id="fref_1997469997" xlink:label="fref_1997469997" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">To calculate the amounts of Compensation Actually Paid to the PEO in each of 2025, 2024 and 2023, the
following adjustments were made to the PEO&#x2019;s Summary Compensation Table Total for each respective year:<xhtml:p style="text-align: justify; margin-top: 0; margin-bottom: 0;"/><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top; text-align: justify;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="width: 0.25in; text-align: justify;">a.</xhtml:td><xhtml:td style="text-align: justify;">Year 2025: None</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top; text-align: justify;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="width: 0.25in; text-align: justify;">b.</xhtml:td><xhtml:td style="text-align: justify;">Year 2024: None</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"><xhtml:tbody><xhtml:tr style="vertical-align: top;"><xhtml:td style="text-align: justify; width: 0.25in;"/><xhtml:td style="text-align: justify; width: 0.25in;">c.</xhtml:td><xhtml:td style="text-align: justify;">Year 2023: We added $50,000, reflecting, as of the applicable vesting date, the change in the fair value during 2023 of equity-based
awards granted to the PEO before 2023 that vested during 2023.</xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_980923542"
          xlink:to="fref_1997469997"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1426426644"
          xlink:to="fref_1997469997"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_82836388"
          xlink:to="fref_1997469997"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_510040926"
          xlink:label="fc_510040926"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_913332359"
          xlink:label="fc_913332359"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1339200806"
          xlink:label="fc_1339200806"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1180171186"
          xlink:label="fc_1180171186"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_344497939"
          xlink:label="fc_344497939"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1346628092"
          xlink:label="fc_1346628092"
          xlink:type="locator"/>
        <link:footnote id="fref_1814506925" xlink:label="fref_1814506925" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The PEO for all years was Jun Ma. The non-PEO NEOs for all years were Jane Moen and Jonathan Newton.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_510040926"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_980923542"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1426426644"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_82836388"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1770273030"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_913332359"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1339200806"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1180171186"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_344497939"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_289300448"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_839152154"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1346628092"
          xlink:to="fref_1814506925"
          xlink:type="arc"/>
        <link:footnote id="fref_1132535968" xlink:label="fref_1132535968" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company&#x2019;s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnotes 3 and 4 below. Equity values are calculated in accordance with FASB ASC Topic 718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_980923542"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1426426644"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_82836388"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1770273030"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_289300448"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_839152154"
          xlink:to="fref_1132535968"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1118739305"
          xlink:label="fc_1118739305"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_745249098"
          xlink:label="fc_745249098"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1719243974"
          xlink:label="fc_1719243974"
          xlink:type="locator"/>
        <link:footnote id="fref_1126958664" xlink:label="fref_1126958664" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The values disclosed in this TSR column represent the measurement period value of an investment of $100 in our common stock as of December 31, 2022, and then valued again on each of December 31, 2023, December 31, 2024 and December 31, 2025. Historical stock performance is not necessarily indicative of future stock performance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1118739305"
          xlink:to="fref_1126958664"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_745249098"
          xlink:to="fref_1126958664"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1719243974"
          xlink:to="fref_1126958664"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
